News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,892 Results
Type
Article (45360)
Company Profile (338)
Press Release (673194)
Section
Business (211515)
Career Advice (2533)
Deals (36903)
Drug Delivery (101)
Drug Development (83780)
Employer Resources (177)
FDA (16697)
Job Trends (15547)
News (358869)
Policy (34499)
Tag
Academia (2692)
Alliances (51718)
Alzheimer's disease (1328)
Approvals (16650)
Artificial intelligence (173)
Bankruptcy (368)
Best Places to Work (11875)
Biotechnology (216)
Breast cancer (207)
Cancer (1554)
Cardiovascular disease (129)
Career advice (2099)
CAR-T (110)
Cell therapy (320)
Clinical research (66912)
Collaboration (584)
Compensation (311)
COVID-19 (2691)
C-suite (137)
Data (1482)
Diabetes (196)
Diagnostics (6362)
Earnings (86967)
Employer resources (154)
Events (114100)
Executive appointments (486)
FDA (17479)
Funding (520)
Gene therapy (231)
GLP-1 (671)
Government (4588)
Healthcare (19196)
Infectious disease (2788)
Inflammatory bowel disease (118)
Interviews (466)
IPO (16820)
Job creations (4096)
Job search strategy (1763)
Layoffs (456)
Legal (8525)
Lung cancer (229)
Manufacturing (224)
Medical device (13471)
Medtech (13476)
Mergers & acquisitions (20328)
Metabolic disorders (523)
Neuroscience (1704)
NextGen: Class of 2025 (6783)
Non-profit (4614)
Northern California (1876)
Obesity (303)
Opinion (229)
Patents (140)
People (58927)
Phase I (20756)
Phase II (29434)
Phase III (22059)
Pipeline (617)
Postmarket research (2681)
Preclinical (9025)
Radiopharmaceuticals (244)
Rare diseases (300)
Real estate (6288)
Regulatory (23003)
Research institute (2432)
Resumes & cover letters (418)
Southern California (1616)
Startups (3764)
United States (16825)
Vaccines (619)
Weight loss (221)
Date
Today (34)
Last 7 days (395)
Last 30 days (1893)
Last 365 days (35629)
2025 (1636)
2024 (36058)
2023 (40901)
2022 (52144)
2021 (56736)
2020 (55336)
2019 (48124)
2018 (36407)
2017 (33636)
2016 (33237)
2015 (39201)
2014 (33042)
2013 (28138)
2012 (30271)
2011 (30994)
2010 (28907)
Location
Africa (845)
Arizona (215)
Asia (41030)
Australia (6660)
California (4265)
Canada (1560)
China (373)
Colorado (192)
Connecticut (207)
Europe (87917)
Florida (599)
Georgia (147)
Illinois (424)
Indiana (248)
Maryland (695)
Massachusetts (3327)
Michigan (198)
Minnesota (316)
New Jersey (1194)
New York (1206)
North Carolina (805)
Northern California (1876)
Ohio (153)
Pennsylvania (1003)
South America (1228)
Southern California (1616)
Texas (621)
Utah (120)
Washington State (435)
718,892 Results for "ani pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex ® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
May 20, 2024
·
4 min read
BioMidwest
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City.
May 29, 2024
·
1 min read
Press Releases
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
September 16, 2024
·
13 min read
Deals
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc. announced they have signed a definitive agreement pursuant to which ANI will acquire Alimera for $5.50 per share in cash at closing and one non-tradable contingent value right representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.
June 24, 2024
·
17 min read
BioMidwest
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the reference listed drug (RLD) Fleqsuvy ® .
April 9, 2024
·
4 min read
Press Releases
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook
January 13, 2025
·
11 min read
Press Releases
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 31, 2024
·
1 min read
Press Releases
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
January 2, 2025
·
5 min read
Business
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
ANI Pharmaceuticals, Inc. announced financial results and business highlights for the three months ended March 31, 2024.
May 10, 2024
·
22 min read
BioMidwest
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
ANI Pharmaceuticals, Inc. announced the launch of Levofloxacin Oral Solution, a generic version of the Reference Listed Drug Levaquin®.
March 27, 2024
·
3 min read
1 of 71,890
Next
